EstechPharma Co. Ltd (041910) — Cash Flow Quality Index
EstechPharma Co. Ltd (041910) has a Cash Flow Quality Index of 6.28x as of December 2025. Operating cash flow of ₩2.38 Billion exceeds net income of ₩379.07 Million, indicating high earnings quality where cash backs reported profits. Explore 041910 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
EstechPharma Co. Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for EstechPharma Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of EstechPharma Co. Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for EstechPharma Co. Ltd (2013–2025)
Year-by-year earnings quality comparison for EstechPharma Co. Ltd. For live market cap and the full company financial profile, see market cap of EstechPharma Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.43x | ₩8.83 Billion | ₩6.16 Billion | ▼ -28.6% |
| 2024 | 2.01x | ₩7.93 Billion | ₩3.95 Billion | ▲ +60.4% |
| 2023 | 1.25x | ₩4.79 Billion | ₩3.82 Billion | ▲ +1326.9% |
| 2021 | 0.09x | ₩603.42 Million | ₩6.87 Billion | ▼ -79.6% |
| 2020 | 0.43x | ₩4.71 Billion | ₩10.96 Billion | ▲ +52.5% |
| 2019 | 0.28x | ₩4.29 Billion | ₩15.23 Billion | ▼ -74.4% |
| 2018 | 1.10x | ₩7.25 Billion | ₩6.59 Billion | ▼ -57.1% |
| 2017 | 2.56x | ₩6.99 Billion | ₩2.73 Billion | ▲ +29.9% |
| 2016 | 1.97x | ₩8.19 Billion | ₩4.15 Billion | ▲ +237.5% |
| 2014 | 0.58x | ₩4.99 Billion | ₩8.54 Billion | ▼ -78.8% |
| 2013 | 2.75x | ₩10.19 Billion | ₩3.70 Billion | — |